Case study highlights a new patient-centric enrollment model that uses a data-driven approach to identify qualified patients first.
Tammy D’Lugin-Monroe
Advertisement
Articles by Tammy D’Lugin-Monroe
Advertisement
Latest Updated Articles
Challenging the ‘Site-first’ Status Quo in Patient EnrollmentPublished: September 1st 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
